NCT03225547 Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer Status TERMINATED Phase PHASE2
NCT03225170 Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling Status COMPLETED Phase NA
NCT03222856 Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes Status COMPLETED Phase PHASE2
NCT03221881 Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer Status COMPLETED Phase NA
NCT03219476 Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT03213925 Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer Status UNKNOWN Phase PHASE2
NCT03211572 The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast Cancers Status UNKNOWN Phase PHASE2
NCT03210441 Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment in Patients Affected by Breast Cancer Status UNKNOWN Phase N/A
NCT03210311 Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema Status COMPLETED Phase NA
NCT03210220 Efficacy of Preoperative Pectoral Nerve Block for Intraoperative Opioid Sparing Effect and Postoperative Analgesia Status COMPLETED Phase NA
NCT03209167 Comparing Patient Satisfaction of the Abdomen After DIEAP Procedure and Conventional Abdominoplasty Status COMPLETED Phase N/A
NCT03206333 Automated Quantification of Coronary Artery Calcifications on Radiotherapy Planning CTs for Cardiovascular Risk Prediction in Breast Cancer Patients: the BRAGATSTON Study Status COMPLETED Phase N/A
NCT03205176 AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas Status COMPLETED Phase PHASE1
NCT03204734 Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT03203252 Pilot Study for 3-Dimensional Surface Imaging in Implant-based Breast Reconstruction Status UNKNOWN Phase N/A